APA (7th ed.) Citation

Spring, L. M., Scarpetti, L., Medford, A. J., Niemierko, A., Comander, A., Mulvey, T., . . . Bardia, A. Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2– breast cancer (LEADER). Nature Portfolio.

Chicago Style (17th ed.) Citation

Spring, Laura M., et al. Adjuvant Endocrine Therapy with Cyclin-dependent Kinase 4/6 Inhibitor, Ribociclib, for Localized Hormone Receptor-positive/HER2– Breast Cancer (LEADER). Nature Portfolio.

MLA (9th ed.) Citation

Spring, Laura M., et al. Adjuvant Endocrine Therapy with Cyclin-dependent Kinase 4/6 Inhibitor, Ribociclib, for Localized Hormone Receptor-positive/HER2– Breast Cancer (LEADER). Nature Portfolio.